Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Mohs

Showing results (1-10 of 192) with videos related to

Pageof 20
Sort By:
Neurobiology of Aging|September 1, 1988
Memory impairment in amnesia and dementia: implications for the use of animal modelsR C Mohs
Genes, Brain, and Behavior|April 7, 2005
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trialsR C Mohs
International Psychogeriatrics|January 1, 1996
The Alzheimer's Disease Assessment ScaleR C Mohs
Schizophrenia Research|September 1, 1995
Assessing cognitive function in schizophrenics and patients with Alzheimer's diseaseR C Mohs
Neurobiology of Aging|November 1, 1995
Methodological aspects of evaluating effects of AD progressionR C Mohs
Psychopharmacology Bulletin|January 1, 1988
Alzheimer's Disease Assessment Scale (ADAS)R C Mohs, L Cohen
Life Sciences|July 15, 1985
Interaction of choline and scopolamine in human memoryR C Mohs, K L Davis
Psychiatry Research|May 1, 1980
Choline chloride effects on memory: correlation with the effects of physostigmineR C Mohs, K L Davis
The American Journal of Psychiatry|November 1, 1982
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmineK L Davis, R C Mohs
Neurobiology of Aging|January 1, 1982
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's diseaseR C Mohs, K L Davis
Pageof 20

Showing results (1-10 of 192) with videos related to

Sort By:
Pageof 20
Neurobiology of Aging|September 1, 1988
Memory impairment in amnesia and dementia: implications for the use of animal modelsR C Mohs
Genes, Brain, and Behavior|April 7, 2005
The clinical syndrome of Alzheimer's disease: aspects particularly relevant to clinical trialsR C Mohs
International Psychogeriatrics|January 1, 1996
The Alzheimer's Disease Assessment ScaleR C Mohs
Schizophrenia Research|September 1, 1995
Assessing cognitive function in schizophrenics and patients with Alzheimer's diseaseR C Mohs
Neurobiology of Aging|November 1, 1995
Methodological aspects of evaluating effects of AD progressionR C Mohs
Psychopharmacology Bulletin|January 1, 1988
Alzheimer's Disease Assessment Scale (ADAS)R C Mohs, L Cohen
Life Sciences|July 15, 1985
Interaction of choline and scopolamine in human memoryR C Mohs, K L Davis
Psychiatry Research|May 1, 1980
Choline chloride effects on memory: correlation with the effects of physostigmineR C Mohs, K L Davis
The American Journal of Psychiatry|November 1, 1982
Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmineK L Davis, R C Mohs
Neurobiology of Aging|January 1, 1982
A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's diseaseR C Mohs, K L Davis
Pageof 20